Director
DIN: 08896052
Mohd Faizanul Haque is currently associated with 2 companies in various capacities such as Individual Promoter and Director. They serve as a Director at FYZEN PHARMACEUTICALS PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 08896052.Mohd Faizanul Haque is currently involved in 2 different roles. Their most recent position is with OLIVER HOSPITAL & RESEARCH CENTRE PRIVATE LIMITED as a Director. The first company Mohd Faizanul Haque was appointed to as a director was FYZEN PHARMACEUTICALS PRIVATE LIMITED. Mohd Faizanul Haque is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Mohd Faizanul Haque is currently associated with 2 companies in various capacities such as Individual Promoter and Director. They serve as a Director at FYZEN PHARMACEUTICALS PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 08896052.Mohd Faizanul Haque is currently involved in 2 different roles. Their most recent position is with OLIVER HOSPITAL & RESEARCH CENTRE PRIVATE LIMITED as a Director. The first company Mohd Faizanul Haque was appointed to as a director was FYZEN PHARMACEUTICALS PRIVATE LIMITED. Mohd Faizanul Haque is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
3
Male
India
Call +91 81049 46419 and we'll pull the verified contact details for you.
Current Companies (2)
Current LLPs (0)
Past Companies (0)
1y 2m 7 Months Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| FYZEN PHARMACEUTICALS PRIVATE LIMITED | Individual Promoter | 28-Sep-2020 |
| FYZEN PHARMACEUTICALS PRIVATE LIMITED | Director | 28-Sep-2020 |
| OLIVER HOSPITAL & RESEARCH CENTRE PRIVATE LIMITED | Director | 26-Nov-2024 |